AVLN vs SPTX: stock comparison and AI forecast
Avalyn Pharma Inc. (AVLN) and Seaport Therapeutics, Inc. (SPTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AVLN Avalyn Pharma Inc.
- Market Cap
- $1.14B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
SPTX Seaport Therapeutics, Inc.
- Market Cap
- $1.07B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- AVLN and SPTX have similar market capitalizations ($1.14B and $1.07B).
- AVLN carries 0.07 times debt per unit of equity, against 0.05 times for SPTX.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AVLN | SPTX |
|---|---|---|
| Market Cap | $1.14B | $1.07B |
| P/B Ratio | 2.85x | 2.70x |
| Book Value/Share | $8.99 | $7.42 |
Financial Health
| Metric | AVLN | SPTX |
|---|---|---|
| Current Ratio | 33.12x | 17.48x |
| D/E Ratio | 0.07x | 0.05x |
| Financial Leverage | 1.07x | 1.05x |
| Working Capital | $347M | $282M |
Dividend & Shareholder Information
| Metric | AVLN | SPTX |
|---|---|---|
| Shares Outstanding | 44M | 54M |
AVLN vs SPTX: stock comparison and AI forecast
Which is bigger, AVLN or SPTX?
AVLN and SPTX have similar market capitalizations ($1.14B and $1.07B).
Which one does Intratio's AI model rank higher, AVLN or SPTX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.